NVO – novo nordisk a/s (US:NASDAQ)
Stock Stats
News
4/24
06:55 pm
nvo
Low
Lilly's New Obesity Pill Off to Slow Start in Race With Novo [Yahoo! Finance Canada]
4/24
11:18 am
nvo
Low
Lilly's New Obesity Pill Off to Slow Start in Race With Novo [Yahoo! Finance]
4/24
11:05 am
nvo
Low
Eli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims [Yahoo! Finance Canada]
4/24
08:23 am
nvo
Medium
Lilly's obesity pill hits nearly 4000 prescriptions in second week after launch [Yahoo! Finance]
4/24
08:12 am
nvo
Medium
Eli Lilly slips as obesity scripts said to trail those for Novo's Wegovy [Seeking Alpha]
2/3/2026
11:38 am
nvo
-2.3%
BEAT
11/6/2025
04:05 pm
nvo
-1.8%
BEAT
11/5/2025
04:04 pm
nvo
-4.1%
BEAT
11/5/2025
07:03 am
nvo
-2.1%
BEAT
3/26
10:00 am
Initiates
Peer Perform
Wolfe Research
Low
-2.1%
3/26
10:00 am
Initiates
Peer Perform
Wolfe Research
Low
-2.1%
3/18
02:00 pm
Initiates
Outperform
Sanford C. Bernstein
Low
0.0%
3/18
12:45 pm
Initiates
UNDERPERFORM
BERNSTEIN
Low
0.7%
3/18
12:45 pm
Initiates
UNDERPERFORM
BERNSTEIN
Low
0.7%
4/20
09:38 am
nvo
Low
Form 6-K NOVO NORDISK A S For: Apr 20
4/20
06:50 am
nvo
Low
Form 6-K NOVO NORDISK A S For: Apr 20
4/13
07:52 am
nvo
Low
Form 6-K NOVO NORDISK A S For: Apr 13
4/7
07:29 am
nvo
Low
Form 6-K NOVO NORDISK A S For: Apr 07
3/30
09:05 am
nvo
Low
Form 6-K NOVO NORDISK A S For: Mar 30
Show more
Top News Gainers
3/17 Form 6-K NOVO NORDISK A S For: Mar 16 6.0%
3/16 Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating. 4.7%
2/5 Q4/2019 12/31/2019 EPS 3.700 ZacksConsensus 0.550 ActVsEst 3.150 - Beat 4.6%
6/8 Novo's oral semaglutide successful in two late-stage T2D studies [Seeking Alpha] 3.8%
11/8 Novo Nordisk: Actual Numbers Not As Good As Headlines But Still Quite Solid [Seeking Alpha] 3.2%
3/27 Form 6-K NOVO NORDISK A S For: Mar 26 3.2%
8/12 Q2/2019 6/30/2019 EPS 4.030 ZacksConsensus 0.610 ActVsEst 3.420 - Beat 3.0%
9/17 With a backup to the backup, insulin makers say they're primed for Brexit [Reuters (UK)] 3.0%
11/1 Form 6-K NOVO NORDISK A S For: Nov 01 2.7%
8/8 Europe stocks climb in early action, led by pharmas [MarketWatch] 2.4%
Top News Decliners
9/9 Form 6-K NOVO NORDISK A S For: Sep 09 -3.6%
11/20 Form 6-K NOVO NORDISK A S For: Nov 20 -2.8%
12/18 Form 6-K NOVO NORDISK A S For: Dec 16 -2.5%
3/9 Form 6-K NOVO NORDISK A S For: Mar 09 -2.4%
4/7 Team Novo Nordisk and Beyond Type 1 Announce New Partnership -2.4%
1/3 Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward [Yahoo! Finance News] -2.2%
4/28 Form 6-K NOVO NORDISK A S For: Apr 27 -2.1%
9/10 Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -2.1%
3/23 Form 6-K NOVO NORDISK A S For: Mar 23 -1.8%
10/1 Form 6-K NOVO NORDISK A S For: Sep 30 -1.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3